4//SEC Filing
Shmagin Martin E 4
Accession 0001013762-09-000458
CIK 0000932352other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:57 PM ET
Size
7.7 KB
Accession
0001013762-09-000458
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-03-18$0.09/sh+1,000$90→ 3,137,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-16$0.08/sh+1,000$80→ 3,135,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-16$0.09/sh+1,000$90→ 3,136,073 total
Documents
Issuer
Urigen Pharmaceuticals, Inc.
CIK 0000932352
Entity typeother
Related Parties
1- filerCIK 0001407236
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:57 PM ET
- Size
- 7.7 KB